Latest Updates

Articles posted in the "Latest Updates" are compiled and published into a bulletin quarterly.

Previously published articles are available within the Noridian Bulletins webpage. Exclusions to this include time-sensitive announcements such as: Noridian and CMS educational Events, Ask-the-Contractor Teleconferences, and claims processing downtime.

The information included in the Latest Updates is also available by subscribing to the Noridian email list. Medicare news, regulations, workshop notices, and other related notifications will be delivered to you each week. Register Now!

Articles Source Posted
Submitting Documentation for Review Nov 19, 2024
Billing and Coding: Lab: Flow Cytometry (A57689) - R11 - Effective October 1, 2024 Nov 15, 2024
New Waived Tests CR13858 Nov 14, 2024
ICD-10 & Other Coding Revisions to NCDs: April 2025 Update (CR 2 of 2) CR13828 Nov 14, 2024
ICD-10 & Other Coding Revisions to NCDs: April 2025 Update (CR 1 of 2) CR13818 Nov 14, 2024
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers Final LCD - Effective February 12, 2025 Nov 14, 2024
Medicare Billing for Physical, Occupational and, Speech Therapy Based on Minutes Nov 14, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - R8 - Effective July 11, 2024 Nov 14, 2024
MLN Connects - November 14, 2024 Nov 14, 2024
2025 Medicare Physician Fee Schedule Now Available Nov 12, 2024
2025 Medicare Physician Fee Schedule Available Soon Nov 11, 2024
Evaluation and Management: Prescription Drug Management Nov 08, 2024
How to Avoid Duplicate and Unbundling Denials - On-Demand Tutorials Available Nov 07, 2024
Top Denials and Solutions Q4 Webinar - 12/18/2024 Nov 07, 2024
Enrollment Opt-Out of Medicare Option Webinar - 12/18/2024 Nov 07, 2024
Preventive and Screening Services Webinar - 12/17/2024 Nov 07, 2024
MLN Connects - November 7, 2024 Nov 07, 2024
MolDX: Blood Product Molecular Antigen Typing (L38331) - R5 - Effective November 7, 2024 Nov 07, 2024
Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (A57423) - R4 - Effective November 7, 2024 Nov 07, 2024
Incarcerated Claim Denials - Resolved 11/04/24 Alert Nov 04, 2024